Suneel Gupta

Dr. Gupta joined as Chief Development Officer in Jan 2019. Dr. Gupta serves on the scientific advisory boards of several pharmaceutical companies. Prior to joining Protagonist, he was Chief Scientific Officer (CSO) of Impax Pharmaceuticals from 2008 to 2019. Prior to Impax, he was Senior Vice President (SVP) and Distinguished Research Fellow at Johnson & Johnson, where he led the early development from 2002-2008. Prior to J&J, he was at ALZA from 1989-2001, where he had increasing levels of responsibility until promoted to Vice President of Clinical Pharmacology & Product Discovery. Dr. Gupta received his PhD in Pharmacokinetics from the University of Manchester, UK in 1987 and did a postdoctoral fellowship in Clinical Pharmacology at the University of California, San Francisco.